Your institution may have access to this item. Find your institution then sign in to continue.
Title
News.
Abstract
The article focuses on the promising results of a large-scale clinical trial for a new malaria vaccine developed by Oxford University and the Serum Institute of India, demonstrating higher efficacy compared to existing vaccines. Topics include the vaccine's safety and effectiveness, its potential impact on malaria prevention and the need for further research to assess its long-term efficacy and geographical coverage.